NASDAQ:OZEM Roundhill GLP-1 & Weight Loss ETF (OZEM) Price, Holdings, & News $32.48 +0.26 (+0.81%) As of 07/24/2026 03:47 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsTrendsBuy This Stock About Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get OZEM alerts:Sign Up Key Stats Today's Range$32.42▼$32.6250-Day Range$29.78▼$33.9952-Week Range$23.22▼$37.15Volume8,549 shsAverage Volume25,992 shsMarket Capitalization$62.69 millionAssets Under ManagementN/ADividend YieldN/ANet Expense Ratio0.59%Aggregate RatingModerate Buy ETF Overview The Roundhill GLP-1 & Weight Loss ETF (OZEM) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies from around the world involved in pharmaceutical drugs and supplements used for weight management. OZEM was launched on May 21, 2024 and is issued by Roundhill. Read More Roundhill GLP-1 & Weight Loss ETF ExpensesTypeOZEMTheme ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.59%0.57%0.57%0.54%0.53%Other Expenses0.00%0.58%0.55%0.51%0.55%Total Expense0.59%0.73%0.76%0.73%0.73%Fee Waiver0.00%-0.75%-0.64%-0.50%-0.62%Net Expense0.59%0.60%0.63%0.63%0.60% Receive OZEM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Roundhill GLP-1 & Weight Loss ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OZEM ETF News HeadlinesRoundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) Shares Down 0.6% - What's Next?July 21, 2026 | americanbankingnews.comThe GLP-1 disclosure dilemma: Should you tell a date you’re using Ozempic for weight loss?July 14, 2026 | msn.comThey’re still buying the wrong AI stocksTesla and Alphabet just tumbled, and many investors concluded AI is over. It isn't - the easy AI trade may be. History shows a similar pattern: Cisco collapsed in 2000, but the internet went on to reshape the world. The lesson applies now as markets question massive AI infrastructure spending. The real opportunity may be Phase 2 AI stocks - companies using AI to dominate cybersecurity, logistics, pharma, and other essential industries.July 26 at 1:00 AM | The Oxford Club (Ad)Medicare opens access to GLP-1 weight-loss drugsJuly 2, 2026 | seekingalpha.comMedicare's GLP-1 Bridge and what's next for biotechJuly 1, 2026 | seekingalpha.com6 FDA-Approved Alternatives To Ozempic For Weight LossJune 24, 2026 | forbes.comSee More Headlines OZEM ETF - Frequently Asked Questions How have OZEM shares performed this year? Roundhill GLP-1 & Weight Loss ETF's stock was trading at $34.16 at the beginning of 2026. Since then, OZEM stock has decreased by 4.9% and is now trading at $32.48. How do I buy shares of Roundhill GLP-1 & Weight Loss ETF? Shares of OZEM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Roundhill GLP-1 & Weight Loss ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Roundhill GLP-1 & Weight Loss ETF investors own include NVIDIA (NVDA), ARM (ARM), Berkshire Hathaway (BRK.B), Chipotle Mexican Grill (CMG), Coinbase Global (COIN), Femasys (FEMY) and Super Micro Computer (SMCI). Fund Details IssuerRoundhill Investments Fund NameRoundhill GLP-1 & Weight Loss ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:OZEM Inception Date5/20/2024 Fund ManagerWill Hershey, Tim Maloney, Dave Mazza, Drew Walsh Previous SymbolNASDAQ:OZEM WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings53 Fund Statistics Assets Under Management$0.00 Average Daily Volume$0.00 Discount/Premium0.00% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorRoundhill Financial, Inc. CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bancorp Fund Services, LLC TrusteeN/A Lead Market MakerOld Mission Options OptionableN/A Short Interest37,600 shs Miscellaneous Outstanding Shares1,930,000Beta0.41 The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report Top 10 OZEM HoldingsNovo Nordisk A/S (NYSE:NVO)Holding Weight: 12.85%Eli Lilly and Company (NYSE:LLY)Holding Weight: 12.51%Pfizer (NYSE:PFE)Holding Weight: 6.25%Viking Therapeutics (NASDAQ:VKTX)Holding Weight: 6.01%CSPC Pharmaceutical Group LimitedHolding Weight: 5.80%Kailera Therapeutics (NASDAQ:KLRA)Holding Weight: 5.76%Chugai Pharmaceutical Co LtdHolding Weight: 4.27%Ascletis Pharma Inc.Holding Weight: 4.17%Zealand Pharma A/SHolding Weight: 3.79%Amgen (NASDAQ:AMGN)Holding Weight: 3.75%Full Holdings DetailsOZEM Sector ExposureOZEM Industry Exposure This page (NASDAQ:OZEM) was last updated on 7/26/2026 by MarketBeat.com Staff. From Our PartnersThe comeback story of the century (ticker inside)In 2013, this struggling PC maker went private amid skepticism from Forbes and the New York Times. Instead of ...InvestorPlace | SponsoredBofA: Digital Dollar Coming 2025-2030Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...Banyan Hill Publishing | SponsoredUniversal basic income is not impossible. It exist (kind of)Robert Kiyosaki, author of Rich Dad Poor Dad, is highlighting an income strategy he calls the Patriot Income P...Freedom Financial | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredThis tiny piece of glass could be bigger than GPUsJensen Huang says AI can't scale without it. Google Ventures calls it the future of AI compute. Sequoia Capita...Brownstone Research | SponsoredOxford Club Analyst’s Urgent AI WarningAlexander Green, Chief Investment Strategist at The Oxford Club, is sharing a private presentation with a warn...The Oxford Club | SponsoredThe 90%-off options that empty accountsA call that cost $3.00 last month now trades for $0.30 - a 90% discount that looks tempting. It's not a bar...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roundhill GLP-1 & Weight Loss ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Roundhill GLP-1 & Weight Loss ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
